ArticleBlood advances2020

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.

Luca Ceriani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.